Clients

Testimonials 

“Biocomm2 has extensive knowledge of Japanese pharma and biotech companies and is close to key decision makers within those companies. As well as introducing important contacts, Andy and Mori-san have followed through with full support during ongoing discussions, negotiation and closing of deals.” – Stephen Hall, CEO Genesis R&D New Zealand

 “I have been delighted with the level and quality of assistance and support that Biocomm squared has provided to us in developing commercial links with the Japanese sector” – Esra Ogru, CEO Phosphagenics Ltd, Australia

“Biocomm2provided our institute with very useful commercial input, informed by a high degree of scientific understanding. Dr Gearing is a commercialisation expert with high scientific credibility and great people skills and this helped facilitate the success of our joint work ”- Donna Hancock Acting General Manager QIMR  Australia

 “Biocomm2 is responsive and diligent and has assisted us in several important commercial projects with tight deadlines . Their breadth of expertise and industry knowledge makes them the choice for most commercial life sciences project and M&A assessments.”- Paul Macleman CEO GTG Australia

“The team from Biocomm squared has consistently provided Opsona with reliable and flexible support for its business development activities from the inception of the Company. Their networks and access to the Japanese and Australian biotechnology and pharma sector is superb” - Mark Heffernan  CEO  Opsona Therapeutics Ireland.

“Biocomm squared provides European companies access to deals with the Asia-Pacific biotech sector”-Mike Wood Research Director Vernalis UK

“Biocomm2 has provided our company with outstanding professional support and specialist services.Truly a superb resource for any aspiring biotechnology company.” - Maurice Fabiani CEO Muranex Australia

“Andy and Mori-san offer emerging biotech companies a high quality source of commercial and business development services” - James Campbell COO and CFO Chemgenex Pharmaceuticals Australia and USA

“OBD has been very impressed with the service that Mori-san has given in supporting all aspects of our partnering activities in Japan, from identifying target companies through logistics and negotiations” - Christian Hoyer-Millar  CEO Oxford Biodynamics  UK